Inc. Emerald Health Therapeutics - Net Worth and Insider Trading
Inc. Emerald Health Therapeutics Net Worth
The estimated net worth of Inc. Emerald Health Therapeutics is at least $0 dollars as of 2024-11-08. Inc. Emerald Health Therapeutics is the 10% Security Holder of Avricore Health Inc and owns about 0 shares of Avricore Health Inc (TSXV:AVCR) stock worth over $0. Details can be seen in Inc. Emerald Health Therapeutics's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Inc. Emerald Health Therapeutics has not made any transactions after 2020-10-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Inc. Emerald Health Therapeutics
Inc. Emerald Health Therapeutics Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Inc. Emerald Health Therapeutics owns 1 companies in total, including Avricore Health Inc (TSXV:AVCR) .
Insider Ownership Summary of Inc. Emerald Health Therapeutics
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSXV:AVCR | Avricore Health Inc | 2020-10-13 | 10% Security Holder |
Inc. Emerald Health Therapeutics Latest Holdings Summary
Inc. Emerald Health Therapeutics currently owns a total of 1 stock. Inc. Emerald Health Therapeutics owns 0 shares of Avricore Health Inc (TSXV:AVCR) as of October 13, 2020, with a value of $0.
Latest Holdings of Inc. Emerald Health Therapeutics
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSXV:AVCR | Avricore Health Inc | 2020-10-13 | 0 | 0.13 | 0 |
Holding Weightings of Inc. Emerald Health Therapeutics
Inc. Emerald Health Therapeutics Form 4 Trading Tracker
According to the SEC Form 4 filings, Inc. Emerald Health Therapeutics has made a total of 5 transactions in Avricore Health Inc (TSXV:AVCR) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Avricore Health Inc is the sale of 891,667 shares on October 13, 2020, which brought Inc. Emerald Health Therapeutics around $98,083.
Insider Trading History of Inc. Emerald Health Therapeutics
- 1
Inc. Emerald Health Therapeutics Trading Performance
Inc. Emerald Health Therapeutics Ownership Network
Ownership Network List of Inc. Emerald Health Therapeutics
Ownership Network Relation of Inc. Emerald Health Therapeutics
Inc. Emerald Health Therapeutics Owned Company Details
What does Avricore Health Inc do?
Who are the key executives at Avricore Health Inc?
Inc. Emerald Health Therapeutics is the 10% Security Holder of Avricore Health Inc. Other key executives at Avricore Health Inc include Senior Officer Kiriaki Smith , and Senior Officer Rodger McKendry Seccombe .
Avricore Health Inc (TSXV:AVCR) Insider Trades Summary
Over the past 18 months, Inc. Emerald Health Therapeutics made no insider transaction in Avricore Health Inc (TSXV:AVCR). Other recent insider transactions involving Avricore Health Inc (TSXV:AVCR) include a net sale of 175,000 shares made by Rodger McKendry Seccombe , and a net sale of 91,500 shares made by Kiriaki Smith .
In summary, during the past 3 months, insiders sold 266,500 shares of Avricore Health Inc (TSXV:AVCR) in total and bought 0 shares, with a net sale of 266,500 shares. During the past 18 months, 266,500 shares of Avricore Health Inc (TSXV:AVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 266,500 shares.
Avricore Health Inc (TSXV:AVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avricore Health Inc Insider Transactions
Inc. Emerald Health Therapeutics Mailing Address
Above is the net worth, insider trading, and ownership report for Inc. Emerald Health Therapeutics. Currently GuruFocus does not have mailing address information for Inc. Emerald Health Therapeutics.